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Abstract  
Correct cell shape is indispensable for tissue architecture, with cell shape being determined 
by cortical actin and surface adhesion. The role of adhesion in remodeling tissue is to 
counteract the deformation of cells by force, resulting from actomyosin contractility, and to 
maintain tissue integrity. The dynamics of this adhesion is critical to the processes of cell 
shape formation and maintenance. Here, we show that the trafficking molecule, Arf6, has a 
direct impact on cell elongation, by acting to stabilize E-cadherin-based adhesion complexes 
at the cell surface, in addition to its canonical role in endocytosis. We demonstrate that these 
functions of Arf6 are dependent on the molecule Flotillin1, which recruits Arf6 to the plasma 
membrane. Our data suggest that Arf6 and Flotillin1 operate in a pathway distinct from 
clathrin-mediated endocytosis. Altogether, we demonstrate that Arf6- and Flotillin1-
dependent regulation of the dynamics of cell adhesion contributes to molding tissue in vivo. 
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Introduction  
Tissue architecture is determined by the shapes of the individual cells of which it is 
composed, with cell shape in the plane of cell-cell adhesion being crucial for the architecture 
of epithelial monolayers [1]. In these epithelia, cell shape in the apical adhesion plane is the 
product of cortical actomyosin and intercellular adhesion [2]. This intercellular adhesion is 
mediated by proteins on the cell surface which bind to molecules on adjacent cells and form 
stable attachments. The primary adhesion molecule in epithelial cells is E-cadherin (E-cad) 
which is instrumental in both the formation and maintenance of tissues [3,4]. In 
morphogenesis, E-cad stabilizes new contacts during cell rearrangements [5] and expands 
contact length between neighbouring cells [6], regulating final tissue architecture. However, 
these adhesion sites are not static but highly dynamic, with alterations in this dynamics 
resulting in abnormal cell shapes and rearrangements [7–10]. Therefore, both the dynamics of 
adhesion and levels are critical to tissue architecture.  
 E-cad molecules at the cell surface are constantly removed from the plasma 
membrane (PM) by the process of endocytosis [9]. These molecules are then either recycled 
or degraded and replaced by newly synthesized molecules [11,12]. Multiple pathways of 
endocytosis exist, with the clathrin-mediated pathway being the best characterised [13]. We 
have recently discovered that clathrin-mediated endocytosis of E-cad from the PM regulates 
shape of epidermal cells in the late Drosophila embryo [7]. At the same time several clathrin-
independent pathways have also been identified [14], and clathrin-independent endocytosis 
has been implicated in Wingless and Notch signalling in Drosophila cells [15,16]. What all 
of the pathways share is the necessity for specific protein mediators to target and traffic 
surface proteins between the surface and cytoplasm. One of these mediator groups are the 
evolutionary conserved small GTPase Arf proteins, a family which participates in all major 
protein trafficking routes known in cells [17,18]. One of its members – Arf6, the sole 
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member of the class III Arfs [17,19,20] – acts at the PM to sort cargo, particularly adhesion 
molecules, in mammalian cells [18,21], and assists the internalisation of these cargos 
including E-cad [22,23]. 
The dynamics of E-cad at the PM is determined by both endocytosis and the motion 
of the molecule itself within the lipid bilayer [12,24]. Techniques such as Fluorescence 
Recovery After Photobleaching (FRAP) have been instrumental in dissecting the mechanisms 
of E-cad dynamics at junctions [12,25–29]. This has revealed the existence of at least several 
subpopulations of E-cad at the cell surface, which are distinguished by their dynamic 
properties and might correspond to E-cad clusters of different sizes and functions [24,29–31]. 
Protein-membrane domains within the PM serve as one of the general mechanism to promote 
such protein clustering [32]. These domains have distinct protein and lipid compositions, and 
their assembly is facilitated by membrane-associated proteins, such as Flotillins [33]. 
Flotillins are a family of proteins embedded within the PM lipid bilayer, where they form 
protrusions into the cytoplasm enabling interactions which can modify the structure of the 
surroundings [33]. Flotillins participate in a range of fundamental cellular processes across 
species: endocytosis, signal transduction, and cortical actin dynamics [33]. In mammalian 
cells, Flotillins have been reported to recruit E-cad and stabilize it at the PM [34,35], but also 
could be potentially involved in E-cad endocytosis and recycling [35,36].  
Here, we demonstrate that Arf6 function contributes to normal tissue architecture in 
an intact tissue in vivo using the Drosophila embryonic epidermis as a model. Arf6 acts both 
by regulating the levels of E-cad at the PM and by enabling the formation of stable adhesion. 
We further show that Arf6 recruitment to the PM is dependent on Flotillin1, and 
downregulation of Flotillin1 has the same effect on E-cad dynamics and cell shape as that of 
Arf6. Taken together, our data demonstrate that Arf6 recruitment to the plasma membrane by 
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Flotillin1 has the effect of stabilizing E-cad intercellular adhesion and thus, regulating 
junctional stability and tissue architecture. 
 
Results and discussion 
To assess the function of Arf6 in general tissue architecture we used the stage 15 Drosophila 
embryonic epidermis, in which cells are highly elongated in the apical plane and rectangular 
in appearance (Fig. 1A-D). This elongation produces two distinct cell borders: a short border 
which is orthogonal to the dorsal-ventral axis (DV), and a long border which faces the 
anterior-posterior axis (AP) of the embryo (Fig. 1A-C). We downregulated Arf6 function 
with a dominant negative variant (Arf6DN ) using the engrailed promoter driving GAL4 in the 
posterior halves of each embryonic segment (en::Gal4, Fig. 1C-D). We co-expressed Arf6DN 
with UAS::CD8-Cherry to label the cells. The cells expressing this construct were visibly 
abnormal (Fig. 1D). Using the aspect ratio of the cells as a measure of correct elongation (the 
ratio between the long and short cell axis, see materials and methods) we found that cells 
expressing Arf6DN were less elongated than in the control expressing UAS::CD8-Cherry alone 
(p=0.04, Fig. 1D-E). A comparable decrease in the aspect ratio was detected in cells upon 
downregulation of Arf6 levels with RNAi (p<0.0001, Fig. 1D-E). To confirm the efficacy of 
this knock-down we used Arf6 transgenically tagged with GFP (UAS::Arf6-GFP, hereafter 
Arf6-GFP) expressed using the en::Gal4 (Fig. 1F). In the presence of the RNAi we observed 
a reduction in Arf-GFP signal relative to control which co-expressed Arf6-GFP with CD8-
cherry (p=0.002, Fig. S1A).  
To determine where Arf6 acts within the cell to promote cell elongation, we examined 
its localisation in our system using Arf6-GFP. In the plane of cell-cell adhesion, Arf6-GFP 
localised predominantly at the PM, overlapping with E-cad (Fig. 1F). In these epidermal cells 
E-cad-GFP localised in a thin belt of ~1 µm depth at the cell-cell junctions, below the apical 
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surface in an approximate 1:2 ratio between the AP and DV cell borders (Fig. 1D,H), 
consistent with previous observations [7,12,37,38]. Here, we used E-cad tagged with GFP 
and expressed from a ubiquitous Ubi-p63E promoter (E-cad-GFP) [39]. Arf6-GFP signal was 
distributed uniformly around the cell periphery, in contrast to E-cad (p=0.77 and p<0.0001, 
respectively, Fig. 1G-H). These observations were consistent with previous reports [40] and 
suggested that Arf6 acts at intercellular junctions. This result raised two related questions. 
First, once at the PM, what does Arf6 do to promote cell elongation? Second, what 
determines the specific enrichment of Arf6 at the PM? We next sought to answer these 
questions. 
 Two known functions of Arf6 could explain its role in cell elongation: vesicle 
trafficking and regulation of the actin cytoskeleton [22]. Indeed, one of the potential Arf6 
regulators – the ArfGEF Steppke – is important for cell morphology and tissue architecture in 
Drosophila embryonic epidermis [41]. First, we tested whether the interaction with cortical 
actomyosin was important for the role of Arf6 in cell elongation. We used a YFP-tagged 
variant of non-muscle Myosin-II under the spaghetti-squash promoter (hereafter, MyoII-
YFP) to visualize the actomyosin cortex (Fig. 2A-B). In control cells at this stage of 
embryonic development, MyoII-YFP was enriched at the AP cell borders, consistent with 
previous observations [7,12,38]. Expression of Arf6DN led to a significant increase in the 
levels of MyoII-YFP at both cell borders (p=0.0001, p=0.04, Fig. 2B), which is consistent 
with Arf6 preventing the formation of actin stress fibres by downregulating RhoA [41,42]. To 
explore this further, we decided to measure the activity of RhoA directly. To this end,  we 
used the biosensor of RhoA-activity, the Rho-binding domain of Anillin (RBD-GFP) [43]. 
This biosensor localised in a similar fashion to MyoII-YFP, with enrichment at the AP cell 
borders but strong cytoplasmic signal (Fig. S1B-B’). The expression of Arf6DN had no effect 
on the localisation and levels of RBD-GFP (p=0.17, Fig. S1B-B’). This indicates that either 
  7 
this biosensor is not sensitive enough to reflect the changes in RhoA activity, or that Arf6 
influences MyoII independently of RhoA activity in this system. Overall, the impairment of 
Arf6 function leads to an increase in MyoII-YFP at the cortex, potentially through a RhoA-
independent mechanism, the existence of which has been reported [44,45].  
MyoII contractility reduces contact length between cells and contributes to cell shape 
[2]. However, the increase in MyoII at the cortex following Arf6 downregulation was 
uniform – about 20% at both AP and DV borders (23 ± 7% and 15 ± 9%, respectively). At 
the same time no change in the apical cell area was observed (p=0.47 and p=0.83 for Arf6 
RNAi and Arf6DN, respectively, Fig. S1C), which would have been expected in the case of a 
uniform contact length reduction. This suggested that the anisotropic change in the cell shape 
following Arf6 downregulation, namely the reduction in cell elongation, is likely to be 
through a different mechanism rather than only cortical actomyosin activity. We next sought 
to determine the contribution of the trafficking function of Arf6 to the cell shape phenotype.  
 Our recent studies have demonstrated key roles for membrane trafficking in the 
regulation of cell shape and specifically in the elongation of cells in the embryonic epidermis 
[7]. Arf6 regulates vesicle trafficking between the PM and endosomal system [22,46,47]. 
Indeed, Arf6 is the primary member of the Arf family which is enriched at the PM, making it 
an obvious candidate to be involved in endocytic trafficking of adhesion proteins. Therefore, 
we explored the effects of Arf6 downregulation on intercellular adhesion by measuring the 
distribution and dynamics of E-cad. In cells expressing Arf6DN, E-cad-GFP was elevated at 
both the AP and DV cell borders in comparison to control (p=0.02 and p=0.007, Fig. 2D), 
indicating a uniform effect consistent with the uniform distribution of Arf6. We confirmed 
the role of Arf6 in E-cad levels at intercellular junctions using an independent approach to 
inhibit Arf6 function: the expression of an RNAi targeted to Arf6 led to a similar increase in 
E-cad-GFP at both the AP and DV cell borders (p=0.0023, p=0.031, Fig. 2C and E).  
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As we have previously found that both the levels of E-cad and its dynamics contribute 
to cell shape [7], we decided to explore the effect of the Arf6DN on the dynamics of E-cad at 
the cell surface using FRAP. In our previous work we showed E-cad-GFP recovered to 70% 
and 50% of pre-bleach signal for the DV and AP cell borders respectively [12,37]. In cells 
expressing the Arf6DN we observed an increased recovery of the E-cad-GFP signal at both 
cell borders (Fig. 2F-G, Supplementary Table 1). Therefore, impairing Arf6 function results 
in the reduction of the immobile E-cad fraction, suggesting that it is involved in stabilising E-
cad within the cell-cell junctions. Overall, these data support a model whereby Arf6 function 
has a dual effect on cell adhesion: to modulate E-cad levels and facilitate the formation of 
stable adhesion complexes.  
Neither the elevation of E-cad at the PM nor the increase in the mobile fraction could 
be explained purely by the Arf6 effect on cortical actomyosin. Myosin II promotes E-cad 
endocytosis in both Drosophila and mammalian cells, and its reduction rather than elevation 
increases E-cad mobility and vice versa [7,8,12,48]. The observed elevation of E-cad at the 
PM by the impairment of Arf6 function was however consistent with defects in E-cad 
endocytosis and the known Arf6 function in vesicle trafficking. Such elevation is also 
observed when E-cad endocytosis is perturbed by other means: for example by 
hyperactivating RhoA signalling or overexpressing p120-catenin (p120ctn), which stabilize 
E-cad [7,49]. However, if the effect of Arf6 was exclusively through an impairment of 
endocytosis it would be predicted to produce an increased amount of immobile E-cad, as 
reported previously when E-cad endocytosis was prevented by inhibiting the function of 
dynamin [12]. This further suggested that Arf6 has an additional function and contributes to 
the formation of the stable fraction of E-cad in addition to its known role in endocytosis.  
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Therefore, we next examined the role of Arf6 in E-cad stability. A key regulator of E-
cad stability at the cell surface is the molecule p120-catenin (p120ctn) [7,37,50,51]. The 
overexpression of p120ctn stabilizes E-cad within junctions in both mammalian and 
Drosophila cells [7,49,52]. If Arf6 were stabilizing E-cad downstream of p120ctn, one might 
expect its increased localisation to the PM upon p120ctn overexpression. However, we found 
that the overexpression of p120ctn, which also elevates Myosin-II [7], did not alter the 
localisation of Arf6 (Fig. 3A-B), from which we concluded that Arf6 is likely to act 
independently of p120ctn.  
We then asked whether Arf6 was involved in clathrin-mediated endocytosis. We used 
a transgenically tagged variant of the clathrin light chain (UAS::CLC-GFP), and analysed the 
effect of Arf6DN on clathrin dynamics by measuring the exchange of CLC-GFP in the plane 
of the cell-cell adhesion using FRAP (Fig. 3C-E). This approach has previously been used to 
identify defects in clathrin-mediated endocytosis in both mammalian and Drosophila cells 
[7,53]. We observed no difference in the CLC-GFP recovery between the control and Arf6DN 
expressing cells (p=0.28, Fig. 3E). Thus, clathrin dynamics was insensitive to the 
downregulation of Arf6 function, suggesting that Arf6 operates in a clathrin-independent 
endocytic pathway in this system. 
Therefore, we explored Arf6 involvement in clathrin-independent endocytic 
pathways. As Drosophila have no orthologues of the mammalian caveolae, we turned to 
Flotillins [54,55]. We used an RNAi targeted against the Flotillin1 protein to downregulate its 
levels. To explore the connection between Flotillin and Arf6, we measured the effect of 
knocking-down Flotillin1 on Arf6-GFP (Fig. 3F-G) [33,56]. We downregulated Flotillin1 
using two independent RNAi lines (results were identical for both). A significant decrease of 
Arf6-GFP at the PM was detected at both cell borders in cells expressing the Flotillin1 RNAi 
(p=0.002, p<0.0001. Fig. 3F-G). This decrease was accompanied by an increase in Arf6-GFP 
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signal in the cytoplasm, suggesting a defect in Arf6 recruitment rather than total protein 
levels (p=0.018, Fig. S1D). Therefore, Arf6 is recruited to the PM downstream of Flotillin1, 
suggesting that Arf6 functions in a Flotillin-mediated pathway.  
Therefore, we wondered if Flotillin1 could be upstream of the stabilizing effect that 
Arf6 had on E-cad, and if the cell shape defect we observed when perturbing Arf6 was due to 
this pathway. We found that the levels of E-cad-GFP were elevated at both the AP and DV 
cell borders upon Flotillin1 downregulation with RNAi (p=0.0025, p=0.0005, Fig. 4A-B), 
similar to what we observed for Arf6 (see Fig. 2C-E). To determine if Flotillin1 was also 
altering the turnover of cell adhesion we measured the dynamics of E-cad-GFP in cells 
expressing Flotillin1 RNAi using FRAP (Fig. 4C-D, Supplementary Table 1). In these cells 
the recovery of E-cad-GFP was elevated at both the AP and DV cell borders, again 
reminiscent of the effect of Arf6DN (see Fig. 2F-G). Altogether, these results suggested that 
Arf6 and Flotillin1 act in the same pathway to stabilize E-cad, with Flotillin1 being required 
for Arf6 localisation to the PM. Indeed, simultaneous downregulation of Flotillin1 by RNAi 
with the expression of Arf6DN did not increase E-cad levels beyond the increase caused by 
either of them alone (p=0.96, p=0.97, Fig. 4F), which further confirms that Flotillin1 and 
Arf6 act in a single pathway. To explore any effect of Flotillin1 on actomyosin, we examined 
the distribution of MyoII-YFP in cells expressing Flotillin1 RNAi. We found no significant 
difference between control cells and those expressing Flotillin1 RNAi at both the AP and DV 
cell borders (p=0.33, p=0.83 respectively Fig. S1E-E’). This finding contrasts with Arf6DN in 
which an elevation of MyoII-YFP was observed (see Fig 2.A-B), potentially due to the 
magnitude of the Arf6 reduction in cells expressing Flotillin1 RNAi being insufficient to 
exert an effect on MyoII. The similarities and differences in the effects of Flotillin1 RNAi 
and Arf6 impairment additionally suggest that Arf6 regulates E-cad and MyoII through 
different and independent mechanisms. 
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Finally, we explored the role of Flotillins in tissue architecture and compared it with 
that of Arf6 (Fig. 4E,G). Similar to the inhibition of Arf6, Flotillin1 RNAi reduced cell 
elongation, measured by aspect ratio, by comparison to control cells (p<0.0001 and p=0.0001 
for two RNAi lines, Fig. 4E,G, Supplementary Table 1). As this reduction of cell elongation 
occurred without any effect on MyoII (see Fig. S1E), we conclude that it is the dynamics of 
adhesion which is the primary contributory mechanism in this phenotype. Furthermore, when 
Flotillin1 RNAi was expressed simultaneously with Arf6DN there was no additive phenotype: 
cell elongation was affected, but it was reduced to the same degree as Flotillin1 RNAi alone 
(p<0.0001 in comparison to control and p=0.59 in comparison to Flotillin1 RNAi, Fig.4E,G). 
Therefore, the stabilization of E-cad by Flotillin-Arf6 is required for correct cell elongation.  
We recently found that hyperstabilization of E-cad, by overexpressing p120ctn or 
inhibiting endocytosis by expressing the dominant-negative variant of dynamin Shibire, has a 
similar phenotype: reduced cell elongation [7]. The current study alongside our previous 
work suggests that the correct dynamics of intercellular adhesion is crucial for cell elongation 
and tissue architecture: if E-cad is too stable or too dynamic cells fail to expand their long 
borders to a normal extent. This further highlights the fact that all E-cad subcomplexes 
contribute to cell shape regulation. However, it is tempting to speculate that they do so 
through different mechanisms: while endocytosis of mobile E-cad enables membrane and 
thus junctional remodeling required for elongation, immobilization of stable E-cad is rather 
more likely to stabilize the junctions following remodeling. Therefore, it is the nature of 
adhesion rather than simply levels, which is crucial for correct tissue architecture.  
 One interesting question which we were unable to address is what accounts for this 
dual function of Arf6 and Flotillin: they are involved in both stabilization and the regulation 
of E-cad levels at the PM, with the latter suggesting an endocytic component. There is 
evidence that “immobile” E-cad despite not exchanging at the cell junctions on the time-scale 
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of a typical FRAP experiment is still turned-over on the scale of approximately 2 hours [26]. 
It is possible that Arf6-Flotllin targets this slow turning over population of E-cad: following 
E-cad recruitment to Flotillin domains in the PM it is internalized due to unknown cues.  
In summary, we have examined the role of stable cell adhesion in tissue architecture 
using the trafficking protein Arf6. We discovered that Arf6 function contributes to tissue 
architecture by regulating cell shape. While Arf6 counteracts cortical actomyosin in what 
appears to be a RhoA-independent manner, this counteraction is not sufficient to explain the 
Arf6 function in tissue architecture. Rather, this function is due to the dual role of Arf6 on 
cell adhesion: both stabilizing and modulating the levels of E-cad. We then uncovered the 
mechanism of this dual role by identifying that Arf6 operates in a clathrin-independent 
pathway in Drosophila and that the Arf6-mediated stabilization of E-cad requires Flotillin1. 
Finally, we showed that Flotillins support the formation of stable adhesion complexes and 
that they function upstream of Arf6 by recruiting it to the PM, which enables the formation 
and regulation of stable cell adhesion and thus correct tissue architecture. 
 
Materials and Methods 
Fly stocks and genetics 
Flies were raised on standard medium. The GAL4/UAS system [57] was used for all the 
specific spatial and temporal expression of transgenic and RNAi experiments. The GAL4 
expressional driver used for all experiments was engrailed::GAL4 (en::GAL4, Bloomington 
number 30564). The following fly stocks were used in this study (Bloomington or Kyoto 
numbers included where applicable): E-cad-GFP (Ubi::E-cadherin-GFP) (109007), E-cad-
mCherry (59014), UAS::CD8-mCherry (27393), UAS::CLC-GFP (7109), UAS::Arf6-GFP 
(65867), UAS::Arf6-T27N (DN) [58], UAS::Arf6 RNAi (27261), Myosin II-YFP (Kyoto 
Stock Center 115082), Anillin-GFP [59],  UAS::p120ctn [7], UAS::ShibireK44A (UAS::Shi-
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DN, 5822), and Flotillin RNAi (36649 and 36700; note, the latter stock is currently not 
available at Bloomington). The p120ctn mutant genotype was (p120ctn308/ Δp120) [7]. 
 
Embryo collection and fixation 
Embryos were collected at 25°C at 3-hour time intervals and allowed to develop at 18°C for 
21 hours to reach the desired developmental stage. Then embryos were dechorionated using 
50% sodium hypochlorite (bleach, Invitrogen) in water for 4 minutes, and extensively 
washed with deionized water prior to fixation. Fixation was performed with a 1:1 solution of 
4% formaldehyde (Sigma) in PBS (Phosphate Buffered Saline) and heptane (Sigma) for 20 
minutes on an orbital shaker at room temperature. Embryos were then devitellinized in 1:1 
solution of methanol and heptane for 20 sec with vigorous agitation. Following subsequent 
methanol washes the fixed embryo specimens were stored at -20°C in methanol until 
required.  
 
Embryo live imaging  
Embryos were collected and dechorionated as described above. Once washed with deionized 
water embryos were transferred to apple juice agar segments upon microscope slide. Correct 
genotypes were selected under a fluorescent microscope (Leica) using a needle. Embryos 
were positioned and orientated in a row consisting of 6-10 embryos per genotype. Following 
this, embryos were transferred to pre-prepared microscope slides with Scotch tape and 
embedded in Halocarbon oil 27 (Sigma). Embryos were left to aerate for 10 minutes prior to 
covering with a cover slip and imaging. 
 
Immunostaining  
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The only embryos which were immunostained for E-cad, are those expressing Arf6-GFP and 
CLC-GFP (Fig. 1F, Fig. 2A, and Fig. 3A,C,D). In all other cases, the native fluorescence of 
GFP and mCherry was imaged. The embryos were washed three times in 1 ml of PBST (PBS 
with 0.05% Triton) with gentle rocking. Blocking of the embryos prior to staining was done 
in 300 µl of a 1% NGS (Normal Goat Serum) in PBST for 1 hour at room temperature with 
gentle rocking. For staining the blocking solution was removed, 300 µl of the primary 
antibody: 1:100 rat anti-E-cad (DCAD2, DSHB) in fresh blocking solution was added and the 
embryos were incubated overnight at 4°C with orbital rotation. Then, embryos were washed 
three times with 1 ml of PBST. A 300 µl 1:300 dilution of the secondary antibody (goat Cy3-
conjugated IgG, Invitrogen) was added, and the embryos incubated either overnight at 4°C 
with orbital rotation or for 2 hours at room temperature. Then embryos were washed three 
time with PBST, following which they were incubated with 50-70 µl of Vectashield (Vector 
Laboratories) and allowed to equilibrate for a period of 2 hours before being mounted on 
microscope slides (Thermo).  
 
Microscopy, data acquisition and FRAP 
All experiments were performed using an up-right Olympus FV1000 confocal microscope 
with a 60x/1.40 NA oil immersion objective. All measurements were made on dorsolateral 
epidermal cells of embryos, which were near or just after completion of dorsal closure, 
corresponding to the end of Stage 15 of embryogenesis. An area encompassing two adjacent 
engrailed domains was imaged to ensure a minimum of 25 cells would be analysed for each 
embryo. For fixed samples 16-bit images were taken at a magnification of 0.051µm/pixel 
(1024x1024 pixel XY-image) with a pixel dwell of 4µm/pixel. For each embryo, a Z-axis 
sectional stack through the plane of the AJs was taken, which consisted of six sections with a 
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0.38 µm intersectional spacing. The images were saved in the Olympus binary image format 
for further processing. 
 For E-cad FRAP (adapted from [12]) 16-bit images were taken at a magnification of 
0.093 µm/pixel (320x320 pixel XY-image). In each embryo, several circular regions of 1 µm 
radius were photobleached at either DV or AP junctions resulting in one bleach event per 
cell. Photobleaching was performed with 8 scans at 2 µs/pixel at 50-70% 488 nm laser 
power, resulting in the reduction of E-cad-GFP signal by 60–80%. A stack of 6 z-sections 
spaced by 0.38 µm was imaged just before photobleaching, and immediately after 
photobleaching, and then at 20 s intervals, for a total of 15 minutes. 
For CLC-GFP FRAP, 16-bit images were taken at a magnification of 0.051µm/pixel 
(256x256 pixel XY-image). In each embryo a single plane was selected in centre of the cell-
cell adhesion band using E-cad-mCherry for positioning. An area encompassing a transverse 
region orthogonal to the axis of the engrailed expressing cells was selected (140x60 pixels) 
was photobleached with 1 scan at 2 µm/pixel using 100% 488nm laser power resulting in 
reduction of CLC-GFP signal by 70-80%. Images were taken using continuous acquisition at 
a frame rate of 2 sec-1. Prior to bleaching a sequence of 10 images was taken, and a total of 
400 frames corresponding to 3.5 minutes were taken.  
 
Data processing and statistical analysis 
Membrane intensity and cell shape: Images were processed in Fiji (https://fiji.sc) by 
generating average intensity projections of the channel required for quantification. Masks 
were created by processing background-subtracted maximum intensity projections using the 
Tissue Analyzer plugin in Fiji [60]. Quantification of the membrane intensity at the AP and 
DV borders and cell elongation (aspect ratio) was done as described previously using a 
custom-built Matlab script [37] found at (https://github.com/nbul/Intensity). In short, cells 
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were identified as individual objects using the created masks, and their eccentricities were 
calculated. The aspect ratio was calculated from the eccentricity as �� = 1/√1 − �!, where 
e is eccentricity. At the same time, the individual borders were identified as objects by 
subtracting a dilated mask of vertices from a dilated mask of cell outlines. The mean intensity 
and orientation of each border were calculated. The average border intensities (0-10° for the 
AP and 40-90° for the DV borders relatively to cell mean orientation) were calculated for 
each embryo and used as individual data points to compare datasets. The average cytoplasmic 
intensity was used for the background subtraction. Statistical analysis was performed in 
Graphpad Prism (https://www.graphpad.com/scientific-software/prism/). First, the data was 
cleaned using ROUT detection of outliers in Prism followed by testing for normal 
distribution (D'Agostino & Pearson normality test). Then, the significance for parametric data 
was tested by either a two-way ANOVA or two-tailed t-test with Welch’s correction.  
E-cad FRAP: images were processed by using the grouped Z-projector plugin in Fiji to 
generate average intensity projections for each time-point. Following this the bleached ROI, 
control ROI and background intensity were manual measured for each time point. This data 
was processed in Microsoft Excel. First the intensity of the bleached ROI at each time point 
was background subtracted and normalized as following: �	# =	 (�# − ��#) (��# − ��#),⁄  
where Fn – intensity of the bleached ROI at the time point n, FCn – intensity of the control 
unbleached ROI of the same size at the plasma membrane at the time point n, and BGn – 
background intensity, measured with the same size ROI in cytoplasm at the time point n. 
Than the relative recovery at each time point was calculated using the following formula: 
�# = (�# − �∃) (�% − �∃)⁄ , where In, I1 and I0 are normalized intensities of bleached ROI and 
time point n, immediately after photobleaching, and before photobleaching respectively. 
These values were input to Prism and nonlinear regression analysis was performed to test for 
best fit model and if recoveries were significantly different between cell borders or 
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genotypes. The recovery was fit to either single exponential model in a form of �(�) = 1 −
	�&∋ − �∃�
() ∗!∀#∃⁄ , or to bi-exponential model in a form of �(�) = 1 − �&∋ − �∃�
() ∗!∀#∃⁄ −
�!�() ∗#%&∋
⁄ , where Fim is a size of the immobile fraction, Tfast and Tslow are the half times, and 
A1 and A2 are amplitudes of the fast and slow components of the recovery. An F-test was used 
to choose the model and compare datasets. 
CLC-GFP FRAP: measurements of all intensities, i.e. the bleached ROI, control ROI and the 
background, and normalization were done using a custom-build Matlab script 
(http://github.com/nbul/FRAP) using the same algorithm as described for E-cad FRAP. 
Curve fitting and statistical analysis was performed in Graphpad Prism using a nonlinear 
regression analysis as described for E-cad FRAP. 
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Figure 1. Arf6 function contributes to correct cell shape and is localised to the Adherens 
junction. 
(A-C) Overview of the stage 15 Drosophila embryonic epidermis. (A) Cartoon sketch of the 
embryo; area indicated by red box is the dorsolateral epidermis imaged in this study. (B) 
Schematic of the cell morphology in the tissue and the two cell borders present in these cells: 
the long anterior-posterior (AP, red) and short dorsal-ventral (DV, blue). (C) Apical view of 
the epidermis highlighted in the red box (A). Cells are outlined by E-cad-GFP (green) and the 
engrailed compartments which express all transgenic construct used in this study are 
highlighted by CD8-mCherry (magenta). (D-E) Examples (D) and aspect ratio (E) of cells 
expressing CD8-mCherry alone (control; magenta, in C), and co-expressing it with the 
Arf6DN (magenta, middle in D) and Arf6-RNAi (magenta, bottom in D). E-cad-GFP marks 
cell morphology (green, left; grey, right images in D). The area of images in D is indicated by 
the box in (C). (F-G). Localisation of the Arf6-GFP in the apical region of the epidermal 
cells corresponding with the plane of cell-cell adherens junction with a representative image 
(F) and quantification (G). Arf6-GFP was expressed in the engrailed (green, left; and grey, 
right in F). (H) Levels of E-cad- GFP at the two cells borders of the epidermal cells. 
Statistical analysis is a two-tailed students t-test with Welch’s correction. Scale bars – 10 μm 
*, p < 0.05; ****, p < 0.0001. Each dot represents an individual embryo, n number was 10-20 
embryos per genotype with a minimum of 28 cells imaged per embryo.   
 
Figure 2. Arf6 function alters both Myosin-II localisation and the levels and dynamics 
of E-cad. 
(A-B) Representative images (A) and levels (B) of MyoII-YFP (Right in A) in the epidermis 
of internal control and Arf6DN expressing embryos. Cell borders were visualized with 
antibody against E-cad (green in A) and cells expressing Arf6DN transgene marked by CD8-
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mCherry (magenta). (C-G) Levels (C-E) and dynamics (F-G) of E-cad in Arf6 knock-down 
or dominant negative. (C-E) Representative images (C) and levels (D-E) of E-cad in cells 
expressing CD8-mCherry alone (Control, top), Arf6DN (middle), or an RNAi against Arf6 
(bottom). (F-G) Representative examples (F) and quantification (G) of E-cad-GFP FRAP in 
control and Arf6DN expressing cells. Panels in F show the region bleached (Position P, red 
circle) at the prebleach (Time T-1), bleach (Time T0), and the end (Time T900) time points. 
Time is in seconds. Average recovery curves (mean ± s.e.m.) and the best-fit curves (solid 
lines) are shown in G. All best-fit and membrane intensity data are in Table S1. Scale bars – 
10 μm. Statistical analysis of the two cell borders between the genotypes was performed 
using a two-way ANOVA. Individual p-values are shown for each border between the 
genotypes are shown above. *, p < 0.05; **, p < 0.01; ***, p < 0.001, ****, p < 0.0001. Each 
dot represents an individual embryo, n number was 10-20 embryos per genotype with a 
minimum of 29 cells imaged per embryo. For FRAP 8-10 embryos were used, with two AP 
and DV cell borders measured per embryo and averaged to give the final embryo value. 
 
Figure 3. Arf6 is separate from clathrin and p120ctn but requires Flotillin1 for 
recruitment to the cell surface. 
(A-B). Representative images (A) and levels (B) of Arf6-GFP (grey, right; green, left in A) in 
control (top in A) and the overexpression of p120ctn (bottom in A). (C-E). Localisation (C) 
and FRAP (D-E) of CLC-GFP (grey, D and right in C; magenta, left in C) in the plane of 
cell-cell adhesion, expressed in the engrailed compartment in control cells (top in C and D) 
and Arf6DN expressing cells (bottom in C and D). Panels in D show the region bleached 
(Position P, red square) at the prebleach (Time T-1), bleach (Time T0), and the end (Time 
T400) time point in seconds. Average recovery curves (mean ± s.e.m.) and the best-fit curves 
(solid lines) are shown in E. All best-fit and membrane intensity data are in Table S1. (F-G) 
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Representative images (F) and levels (G) of Arf6-GFP (grey, right; green, left in F) in control 
(top in F) and Flotillin RNAi expressing cells (bottom in F). Scale bars – 10 μm. Cell borders 
were visualized with antibody against E-cad (magenta, left in A, C, and F). Statistical 
analysis was performed using a two-way ANOVA. p-values are shown for each border type 
between the genotypes. **, p < 0.01; ****, p < 0.0001. Each dot represents an individual 
embryo, n number was 10-20 embryos per genotype with a minimum of 35 cells imaged per 
embryo. For FRAP 8-10 embryos were used, with a single rectangular band encompassing an 
engrailed stripe used per embryo. 
 
Figure 4. Flotillin determines cell shape and E-cad dynamics upstream of Arf6. 
(A-B). Representative images (A) and levels (B) of E-cad-GFP (green, left; and grey, right in 
A) in control (top in A) and Flotillin1 RNAi expressing cells (bottom in A). (C-D) 
Representative examples (C) and quantification (D) of E-cad-GFP FRAP in control and 
Flotillin1 RNAi expressing cells. Panels in C show the region bleached (Position P, red 
circle) at the prebleach (Time T-1), bleach (Time T0), and the end (Time T900) time points. 
Time is in seconds. Average recovery curves (mean ± s.e.m.) and the best-fit curves (solid 
lines) are shown in D. (E-F) Representative images (E) and levels (F) of E-cad-GFP (green, 
left: grey, right in E) in cells expressing either: Flotillin1 RNAi alone (top in E), Arf6DN 
alone (middle in E), or both Flotillin1 RNAi and Arf6DN (bottom in E). (F) E-cad-GFP levels 
at cell borders in cells expressing: Arf6DN alone (blue), Flotillin1 RNAi alone (purple), or 
both: Arf6DN and Flotillin1 RNAi (black). (G) Aspect ratio of the cells expressing Flotillin1 
RNAi alone, Arf6DN alone, or both Flotillin1 RNAi and Arf6DN. Scale bars – 10 μm. RNAi 
expressing cells marked by CD8-mCherry (magenta, left in A and E). Statistical analysis was 
performed using a two-way ANOVA. p-values are shown for each border type between the 
genotypes. For analysis of aspect ratios, a one-way ANOVA with Turkeys multiple 
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comparison test was used. *, p < 0.05; **, p < 0.01; ***, p < 0.001.  ****, p < 0.0001. Each 
dot represents an individual embryo, n number was 10-20 embryos per genotype with a 
minimum of 29 cells imaged per embryo. For FRAP 8-10 embryos were used, with two AP 
and DV cell borders measured per embryo and averaged to give the final embryo value. 
 
Supplementary information 
Table S1. Numerical values for each experiment presented in paper. 
 
Figure S1. Control measures of Arf6 RNAi efficacy and the Arf6-Flotillin pathway is 
independent of RhoA and actomyosin.  
(A) Quantification of the efficacy of Arf6 RNAi on Arf6-GFP intensity in the epidermal 
cells. (B) Representative images of RBD-GFP localisation in the epidermal cells of control 
and Arf6DN expressing embryos. Cell borders were visualized with antibody against E-cad 
(green in B) and cells expressing transgene marked by CD8-mCherry (magenta). (B’) 
Quantification of the levels of RBD-GFP at the AP and DV cell borders between control and 
Arf6DN expressing cells. (C) Apical cell area of the cells expressing CD8-mCherry alone 
(red, Control), Arf6DN (blue), or Arf6 RNAi alone (purple). (D) Quantification of the 
cytoplasmic intensity of Arf6-GFP between control and Flotillin1 expressing cells. (E) 
Representative images of MyoII-YFP localisation in the epidermal cells of control and 
flotillin1 RNAi expressing embryos. (E’) Quantification of MyoII-YFP at both the AP and 
DV cell borders between the control and Flotillin1 RNAi expressing cells. For A and C, 
statistical analysis is a two-tailed students t-test with Welch’s correction. Scale bars – 10 μm 
*, p < 0.05; **, p < 0.001. For B and D, statistical analysis of the two cell borders between 
the genotypes was performed using a two-way ANOVA. Individual p-values are shown for 
each border between the genotypes are shown above. Each dot represents an individual 
  30 
embryo, n number was 10-20 embryos per genotype with a minimum of 24 cells imaged per 
embryo. 
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